Article History
Received: 17 November 2017
Accepted: 20 February 2018
First Online: 16 April 2018
Competing interests
: H.M.A.-H. is an advisor to and holds a financial interest in Nymirum, an RNA-based drug discovery company. The remaining authors declare no competing interests.